Result of General Meeting / Issue of Equity

RNS Number : 7761Y

e-Therapeutics plc

27 February 2013

 

27 February 2013

e-Therapeutics plc ("e-Therapeutics" or the "Company")

Result of General Meeting / Issue of Equity

On 11 February 2013, e-Therapeutics plc (AIM: ETX) announced plans to raise £40 million through the issue of 125,000,000 new ordinary shares at 32 pence per share. The transaction was conditional upon shareholder approval. The Company is pleased to announce that a general meeting of its shareholders today passed resolutions providing such approval.

The fundraising will be effected in two stages (the "First Placing" and the "Second Placing") in order to allow qualifying investments to be made by certain venture capital trust and enterprise investment scheme funds. The Company has today issued and allotted 4,750,000 new ordinary shares to effect the First Placing. Application has been made to admit the 4,750,000 new ordinary shares to trading on AIM and dealings in these shares are expected to commence on 28 February 2013.

Completion of both placings is conditional upon admission occurring on or before 8.00 a.m. on 15 March 2013 (or such later date as the parties may agree).

-Ends-

For more information, please contact:

e-Therapeutics plc

Daniel Elger

Tel: [phone]

www.etherapeutics.co.uk 

Panmure Gordon (UK) Limited

Corporate Finance: Fred Walsh / Grishma Patel

Corporate Broking: Hannah Woodley

Tel: [phone]

www.panmure.com

 

END

 

 

ROMUBVKROWAUURR